We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
+15.7%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$550M
AUM Growth
+$193M
Cap. Flow
+$66.2M
Cap. Flow %
12.03%
Top 10 Hldgs %
37.74%
Holding
95
New
27
Increased
22
Reduced
33
Closed
9

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$20.4M
2
NEE icon
NextEra Energy
NEE
+$17.3M
3
ADBE icon
Adobe
ADBE
+$16.2M
4
LITE icon
Lumentum
LITE
+$11.7M
5
FISV
Fiserv Inc
FISV
+$11M

Sector Composition

Rank Sector Weight
1 Technology 26.99%
2 Healthcare 19.78%
3 Financials 11.08%
4 Industrials 10.58%
5 Consumer Discretionary 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMI icon
26
Cummins
CMI
$91.7B
$9.88M 1.8%
+46,800
New +$9.32M
ALXN
27
DELISTED
Alexion Pharmaceuticals
ALXN
$9.72M 1.77%
8,500
+2,250
+36% +$243K
APD icon
28
Air Products & Chemicals
APD
$66.3B
$9.22M 1.68%
+30,950
New +$8.9M
CTAS icon
29
Cintas
CTAS
$82.4B
$8.57M 1.56%
103,000
+96,600
+1,509% +$7.45M
SPY icon
30
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$7.84M 1.42%
+23,415
New +$7.76M
CCI icon
31
Crown Castle
CCI
$32.7B
$7.79M 1.42%
46,800
-700
-1% -$116K
AVGO icon
32
Broadcom
AVGO
$1.82T
$7.78M 1.41%
213,500
+201,500
+1,679% +$6.75M
STM icon
33
STMicroelectronics
STM
$46B
$7.33M 1.33%
239,000
-65,000
-21% -$1.91M
HOLX
34
DELISTED
Hologic
HOLX
$6.28M 1.14%
+94,500
New +$5.98M
DHR icon
35
Danaher
DHR
$135B
$5.86M 1.06%
30,670
-903
-3% -$161K
MSCI icon
36
MSCI
MSCI
$40B
$4.82M 0.88%
+13,500
New +$4.9M
LULU icon
37
lululemon athletica
LULU
$13B
$4.38M 0.8%
13,300
-4,500
-25% -$1.5M
VZ icon
38
Verizon
VZ
$194B
$4.06M 0.74%
68,265
-1,100
-2% -$63.9K
AKAM icon
39
Akamai
AKAM
$16.8B
$4.04M 0.73%
+36,521
New +$4.05M
CHGG icon
40
Chegg
CHGG
$108M
$4.01M 0.73%
+56,100
New +$4.13M
AMT icon
41
American Tower
AMT
$77.7B
$3.78M 0.69%
15,620
-3,750
-19% -$951K
MASI
42
DELISTED
Masimo
MASI
$3.39M 0.62%
14,350
-300
-2% -$67.3K
UNH icon
43
UnitedHealth
UNH
$382B
$3.1M 0.56%
9,950
+2,200
+28% +$676K
ILMN icon
44
Illumina
ILMN
$29.4B
$2.92M 0.53%
9,702
+190
+2% +$65.5K
ABBV icon
45
AbbVie
ABBV
$458B
$2.8M 0.51%
31,950
-100,350
-76% -$9.45M
REGN icon
46
Regeneron Pharmaceuticals
REGN
$68.8B
$2.66M 0.48%
+4,750
New +$2.88M
ICE icon
47
Intercontinental Exchange
ICE
$82.4B
$2.25M 0.41%
+22,500
New +$2.22M
EW icon
48
Edwards Lifesciences
EW
$47.6B
$1.96M 0.36%
24,600
-6,300
-20% -$492K
DBX icon
49
Dropbox
DBX
$6.81B
$1.96M 0.36%
+101,500
New +$2.11M
GIS icon
50
General Mills
GIS
$19.2B
$1.82M 0.33%
29,450
-400
-1% -$25K

Similar funds

De Burlo Group's Q3 2020 Portfolio in Review

As of Q3 2020, De Burlo Group held 95 positions worth $550M, up 54% from $357M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

De Burlo Group deployed $66.2M of net new capital in Q3 2020, opening 27 new positions and adding to 22 existing holdings. Its largest new stake was Canadian Pacific Kansas City: 257,500 shares worth $15.7M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $20.4M trimmed.

  • De Burlo Group's largest Q3 2020 buy was Canadian Pacific Kansas City: 257,500 shares worth $15.7M.
  • De Burlo Group added most to Church & Dwight Co in Q3 2020, an estimated $17.8M increase.
  • De Burlo Group's biggest Q3 2020 reduction was Vertex Pharmaceuticals, cutting an estimated $20.4M.
  • De Burlo Group fully exited Lumentum in Q3 2020, selling an estimated $11.7M.
  • De Burlo Group's ten largest holdings make up 38% of its $550M portfolio in Q3 2020.
  • De Burlo Group opened 27 new positions and closed 9 in Q3 2020.
  • De Burlo Group's portfolio value rose 54% quarter-over-quarter to $550M.

Based on De Burlo Group's 13F filing for Q3 2020, filed 5 Nov 2020.